Understanding how cancer cells use energy
Tumor cell metabolism in action
This project helps us understand how cancer cells get their energy, which could lead to new ways to treat different types of cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11083665 on NIH RePORTER |
What this research studies
Cancer cells have unique ways of using energy that set them apart from healthy cells, which is important for both detecting cancer and creating new treatments. This project aims to uncover these special metabolic features by developing advanced techniques to look closely at how cancer cells and immune cells within a tumor each use energy. By understanding these differences at a cellular level, we hope to find new targets to fight cancer more effectively. The ultimate goal is to provide a basis for manipulating metabolism to improve cancer treatment.
Who could benefit from this research
Good fit: Patients with various types of cancer, particularly those where current treatments are less effective, could potentially benefit from future therapies developed from this foundational research.
Not a fit: Patients whose cancer does not rely on the specific metabolic pathways being studied may not directly benefit from therapies developed through this particular research.
Why it matters
Potential benefit: If successful, this work could lead to the development of new anti-cancer drugs that specifically target the unique energy pathways of tumor cells, improving treatment options for patients.
How similar studies have performed: This project builds upon previous discoveries in tumor metabolism and aims to develop novel methods for a more detailed, cell-type-specific understanding, suggesting a blend of established knowledge and new approaches.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: White, Eileen P. — Rutgers Biomedical and Health Sciences
- Study coordinator: White, Eileen P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.